Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Osteoclast differentiation	12/127	8.318914146876878E-5	0.025622255572380785	0	0	3.779527559055118	35.50637000257179	CSF1R;SPI1;NCF1;BTK;LILRB1;LILRA1;MAP2K7;LILRA2;FCGR2C;OSCAR;LILRA5;MAPK3
Fc gamma R-mediated phagocytosis	7/91	0.007793448162696157	1.0	0	0	3.076923076923077	14.93683654587159	MARCKSL1;NCF1;INPPL1;WAS;PLCG1;PLA2G6;MAPK3
Vibrio cholerae infection	5/50	0.008040893507605765	0.8255317334475252	0	0	4.0	19.292860276717064	KCNQ1;ADCY3;PLCG1;PRKACA;ATP6V1D
Chemokine signaling pathway	11/190	0.008476604918739727	0.652698578742959	0	0	2.31578947368421	11.047346947308263	GSK3A;NCF1;CCL7;GNG4;WAS;ADCY3;ARRB1;PRKACA;RASGRP2;PLCB2;MAPK3
Human T-cell leukemia virus 1 infection	12/219	0.009297026498108457	0.572696832283481	0	0	2.191780821917808	10.2532836412802	KAT2A;CD4;SPI1;CRTC1;ADCY3;BAX;VDAC1;LTBR;PRKACA;RAN;ANAPC2;MAPK3
Hematopoietic cell lineage	7/97	0.010898290499560565	0.5594455789774423	0	0	2.8865979381443294	13.044967158205083	CSF1R;CD4;CR1;ITGA2;CD59;CD1D;CD33
Prion diseases	4/35	0.010945733656667284	0.48161228089336044	0	0	4.571428571428571	20.639110944169403	PRNP;BAX;PRKACA;MAPK3
Lysosome	8/123	0.012178081291260126	0.4688561297135148	0	0	2.6016260162601625	11.468273323089807	ARSA;ABCA2;CTSL;IDUA;GAA;ARSG;CTSV;GLA
Platelet activation	8/124	0.012743171259005495	0.4360996386415214	0	0	2.5806451612903225	11.258734808735266	ITGA2;P2RX1;BTK;ADCY3;PRKACA;RASGRP2;PLCB2;MAPK3
MAPK signaling pathway	14/295	0.016944894602505305	0.5219027537571634	0	0	1.8983050847457628	7.740887012184362	CSF1R;CACNA2D3;ARRB1;HSPA2;RASGRP2;MAPK8IP3;RASGRP4;PPP5C;DUSP10;STMN1;PRKACA;MAP2K7;MET;MAPK3
Ferroptosis	4/40	0.017333054887491272	0.48532553684975566	0	0	4.0	16.220559653524184	PRNP;SLC7A11;GCLM;SLC39A14
Calcium signaling pathway	10/188	0.0201599003415028	0.5174374420985718	0	0	2.127659574468085	8.306510168444733	PDE1B;P2RX1;ADCY3;VDAC1;PLCG1;CAMK1;PRKACA;PLCB2;SLC8A1;TPCN1
Insulin signaling pathway	8/137	0.021940705845488007	0.5198259538777159	0	0	2.335766423357664	8.921253496118961	HK3;RHEB;INPPL1;PYGL;PRKACA;ACACB;SH2B2;MAPK3
Cholinergic synapse	7/112	0.022431444848228562	0.4934917866610284	0	0	2.5	9.493228791607109	GNG4;KCNQ1;CHRNA6;ADCY3;PRKACA;PLCB2;MAPK3
Protein processing in endoplasmic reticulum	9/165	0.023178649070952396	0.47593492759022255	0	0	2.1818181818181817	8.213506304095702	GANAB;HSPH1;PRKCSH;BAX;CAPN1;HSPA2;BAK1;MAP2K7;EIF2S1
Hepatocellular carcinoma	9/168	0.0256658294226503	0.4940672163860183	0	0	2.142857142857143	7.848417356197167	NQO1;SMARCD3;FZD7;TXNRD1;BAX;PLCG1;BAK1;MET;MAPK3
Dilated cardiomyopathy (DCM)	6/91	0.02655314694507905	0.4810805446520204	0	0	2.6373626373626373	9.569952552035172	ITGA2;LMNA;CACNA2D3;ADCY3;PRKACA;SLC8A1
Thyroid hormone signaling pathway	7/116	0.02655573707700826	0.45439816776214137	0	0	2.413793103448276	8.75847113176563	KAT2A;RHEB;SLC16A10;PLCG1;PRKACA;PLCB2;MAPK3
Apoptosis	8/143	0.02746832926218893	0.4452760743554837	0	0	2.2377622377622375	8.044132254380749	CTSL;LMNA;BAX;CAPN1;CTSV;BAK1;EIF2S1;MAPK3
Adrenergic signaling in cardiomyocytes	8/145	0.02950760986159896	0.45441719186862395	0	0	2.206896551724138	7.775132882742184	PPP2CB;KCNQ1;CACNA2D3;ADCY3;PRKACA;PLCB2;SLC8A1;MAPK3
Taurine and hypotaurine metabolism	2/11	0.02954667996708659	0.43335130618393664	0	0	7.2727272727272725	25.612973778194785	GGT7;CSAD
Leishmaniasis	5/74	0.037751290429200716	0.52851806600881	0	0	2.7027027027027026	8.856042217071249	MARCKSL1;CR1;NCF1;FCGR2C;MAPK3
Thyroid hormone synthesis	5/74	0.037751290429200716	0.5055390196606009	0	0	2.7027027027027026	8.856042217071249	ADCY3;PRKACA;PLCB2;ASGR1;ASGR2
Glioma	5/75	0.03965117281127439	0.508856717744688	0	0	2.6666666666666665	8.607026005972685	BAX;PLCG1;BAK1;CAMK1;MAPK3
Galactose metabolism	3/31	0.04160691113161275	0.512597145141469	0	0	3.8709677419354835	12.307699325969082	HK3;GAA;GLA
Relaxin signaling pathway	7/130	0.0449669377075316	0.5326852620738359	0	0	2.1538461538461537	6.680859827081968	GNG4;ADCY3;ARRB1;PRKACA;MAP2K7;PLCB2;MAPK3
Apelin signaling pathway	7/137	0.056647697881061373	0.6462033684209963	0	0	2.043795620437956	5.867540878657185	GNG4;SPP1;ADCY3;PRKACA;PLCB2;SLC8A1;MAPK3
Starch and sucrose metabolism	3/36	0.06037988610364689	0.6641787471401158	0	0	3.333333333333333	9.356997470103483	HK3;GAA;PYGL
Thyroid cancer	3/37	0.06453588403923348	0.6854155960028936	0	0	3.2432432432432434	8.888217950878486	BAX;BAK1;MAPK3
Phenylalanine metabolism	2/17	0.0662415915707929	0.6800803401268071	0	0	4.705882352941176	12.773867020503221	GOT1;ALDH3B1
Glutamatergic synapse	6/114	0.06653353765237376	0.6610428902235844	0	0	2.1052631578947367	5.705366595473973	HOMER1;GNG4;ADCY3;PRKACA;PLCB2;MAPK3
Morphine addiction	5/91	0.07788799770256499	0.7496719778871881	0	0	2.1978021978021975	5.609853650799394	PDE1B;GNG4;ADCY3;ARRB1;PRKACA
Acute myeloid leukemia	4/66	0.08305732510112497	0.7752017009438331	0	0	2.4242424242424243	6.03205877749113	CSF1R;SPI1;PPARD;MAPK3
Non-small cell lung cancer	4/66	0.08305732510112497	0.7524016509160733	0	0	2.4242424242424243	6.03205877749113	BAX;PLCG1;BAK1;MAPK3
GnRH signaling pathway	5/93	0.08369783822179734	0.7365409763518166	0	0	2.150537634408602	5.334499203261968	ADCY3;PRKACA;MAP2K7;PLCB2;MAPK3
Ribosome	7/153	0.08983391585784943	0.768579057894934	0	0	1.830065359477124	4.41007813064962	MRPS11;MRPL17;MRPL14;MRPL36;MRPL13;MRPL32;MRPS18C
Fc epsilon RI signaling pathway	4/68	0.09037481756509516	0.7523092921634948	0	0	2.352941176470588	5.655975569761716	BTK;PLCG1;MAP2K7;MAPK3
Oocyte meiosis	6/125	0.09379617151331575	0.760242653318454	0	0	1.92	4.543931979313926	PPP2CB;ADCY3;PRKACA;YWHAG;ANAPC2;MAPK3
Arginine biosynthesis	2/21	0.09588684119947874	0.7572601817804988	0	0	3.8095238095238093	8.931758172484527	ARG2;GOT1
Circadian entrainment	5/97	0.09598139817691856	0.7390567659622729	0	0	2.0618556701030926	4.832166753155399	GNG4;ADCY3;PRKACA;PLCB2;MAPK3
Vasopressin-regulated water reabsorption	3/44	0.09705771960273352	0.7291165277473639	0	0	2.727272727272727	6.361225718177528	ADCY3;PRKACA;DYNLL1
Autophagy	6/128	0.1021348091644353	0.7489886005391923	0	0	1.875	4.277740649708972	PPP2CB;RHEB;CTSL;PRKACA;EIF2S1;MAPK3
Choline metabolism in cancer	5/99	0.10244796021859995	0.7338132964495067	0	0	2.02020202020202	4.602828918210063	RHEB;WAS;PLCG1;DGKZ;MAPK3
Inflammatory mediator regulation of TRP channels	5/100	0.10576065482120137	0.7403245837484096	0	0	2.0	4.4931534226415195	ADCY3;PLCG1;PRKACA;PLA2G6;PLCB2
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	4/72	0.10589336254947611	0.7247812370053031	0	0	2.222222222222222	4.989606010945918	ITGA2;LMNA;CACNA2D3;SLC8A1
Melanoma	4/72	0.10589336254947611	0.7090251231573618	0	0	2.222222222222222	4.989606010945918	BAX;BAK1;MET;MAPK3
Melanogenesis	5/101	0.10912554395411007	0.7151205859120404	0	0	1.9801980198019802	4.386646099300001	FZD7;ADCY3;PRKACA;PLCB2;MAPK3
Ribosome biogenesis in eukaryotes	5/101	0.10912554395411007	0.7002222403722063	0	0	1.9801980198019802	4.386646099300001	AK6;REXO2;RPP38;NOP10;RAN
Mismatch repair	2/23	0.11187435504137663	0.7032102316886532	0	0	3.4782608695652173	7.618709103989623	PCNA;RPA3
Longevity regulating pathway	5/102	0.11254203614215841	0.6932589426356958	0	0	1.9607843137254901	4.283193083396457	RHEB;ADCY3;BAX;HSPA2;PRKACA
Nucleotide excision repair	3/47	0.11266904115423244	0.6804326406961488	0	0	2.553191489361702	5.57438450312141	PCNA;CETN2;RPA3
Inositol phosphate metabolism	4/74	0.11407613801901988	0.6756817405741947	0	0	2.1621621621621623	4.693814434937615	INPPL1;PLCG1;PLCH2;PLCB2
Pathways in cancer	18/530	0.11800033043027373	0.6857377692929115	0	0	1.3584905660377358	2.9031865189999277	CSF1R;NQO1;SPI1;FZD7;ITGA2;TXNRD1;ADCY3;RASGRP2;RASGRP4;GNG4;BAX;PLCG1;BAK1;PRKACA;PLCB2;MET;PPARD;MAPK3
Endocrine and other factor-regulated calcium reabsorption	3/48	0.11807273003133849	0.6734518675861528	0	0	2.5	5.341136220470389	PRKACA;PLCB2;SLC8A1
Gastric acid secretion	4/75	0.11826909586753341	0.6623069368581872	0	0	2.1333333333333333	4.5542245917778965	KCNQ1;ADCY3;PRKACA;PLCB2
Neomycin, kanamycin and gentamicin biosynthesis	1/5	0.11891526936765551	0.6540339815221053	0	0	8.0	17.03475249279432	HK3
Phenylalanine, tyrosine and tryptophan biosynthesis	1/5	0.11891526936765551	0.6425597011445245	0	0	8.0	17.03475249279432	GOT1
Spliceosome	6/134	0.11992924955826728	0.6368656700680401	0	0	1.7910447761194028	3.7985432186674037	PRPF4;SF3A2;U2AF2;BUD31;HSPA2;USP39
Arginine and proline metabolism	3/49	0.12357090514220292	0.6450820132847203	0	0	2.4489795918367343	5.120669772142008	ALDH4A1;ARG2;GOT1
Malaria	3/49	0.12357090514220292	0.6343306463966416	0	0	2.4489795918367343	5.120669772142008	CR1;LRP1;MET
Human papillomavirus infection	12/330	0.12623747792927187	0.637395790200258	0	0	1.4545454545454544	3.010313309766452	PPP2CB;RHEB;FZD7;ITGA2;COL6A2;SPP1;BAX;RFNG;BAK1;PRKACA;ATP6V1D;MAPK3
Parathyroid hormone synthesis, secretion and action	5/106	0.1267114019022413	0.629469544933715	0	0	1.8867924528301887	3.8978173667325606	ADCY3;ARRB1;PRKACA;PLCB2;MAPK3
alpha-Linolenic acid metabolism	2/25	0.12848911332067864	0.6281689984566511	0	0	3.1999999999999997	6.566115518322446	FADS2;PLA2G6
Ras signaling pathway	9/232	0.12887640394885932	0.6202176940038855	0	0	1.5517241379310345	3.179329825071374	CSF1R;GNG4;PLCG1;PRKACA;PLA2G6;RASGRP2;MET;RASGRP4;MAPK3
Cholesterol metabolism	3/50	0.12916025190606503	0.6120208859548928	0	0	2.4	4.912083318606716	LRP1;OSBPL5;VDAC1
Proteoglycans in cancer	8/201	0.1322792309955723	0.6173030779793374	0	0	1.5920398009950247	3.220442116370119	CTSL;FZD7;ITGA2;RDX;PLCG1;PRKACA;MET;MAPK3
Viral carcinogenesis	8/201	0.1322792309955723	0.6080895992035263	0	0	1.5920398009950247	3.220442116370119	KAT2A;HDAC10;BAX;BAK1;LTBR;PRKACA;YWHAG;MAPK3
Tight junction	7/170	0.13482594988025015	0.6106822435752507	0	0	1.6470588235294117	3.3003280347073467	PPP2CB;PCNA;RDX;WAS;CD1D;PRKACA;MAP2K7
Complement and coagulation cascades	4/79	0.13568722199833994	0.6056762952969377	0	0	2.0253164556962022	4.045372921890401	CR1;SERPINB2;CD59;TFPI
NOD-like receptor signaling pathway	7/178	0.1592170991083891	0.7005552360769121	0	0	1.5730337078651684	2.8904283672266273	CARD9;VDAC1;TXN;TP53BP1;MEFV;PLCB2;MAPK3
Hypertrophic cardiomyopathy (HCM)	4/85	0.16359856361460354	0.7096951773703928	0	0	1.8823529411764706	3.4076981359319904	ITGA2;LMNA;CACNA2D3;SLC8A1
Phospholipase D signaling pathway	6/148	0.16683342934024545	0.7136763366221611	0	0	1.6216216216216217	2.903934151506698	RHEB;ADCY3;PLCG1;DGKZ;PLCB2;MAPK3
Endometrial cancer	3/58	0.17675775807092875	0.7457724587102199	0	0	2.068965517241379	3.5854656874425306	BAX;BAK1;MAPK3
Neurotrophin signaling pathway	5/119	0.17784346282582597	0.7402133317615459	0	0	1.680672268907563	2.90227149232865	BAX;PLCG1;MAP2K7;SH2B2;MAPK3
Gap junction	4/88	0.1782707420189226	0.7320985138910422	0	0	1.8181818181818181	3.1353670212637206	ADCY3;PRKACA;PLCB2;MAPK3
mTOR signaling pathway	6/152	0.1814837820990341	0.7354869064013487	0	0	1.5789473684210524	2.694614185414532	RHEB;FZD7;TBC1D7;ATP6V1D;TELO2;MAPK3
Oxytocin signaling pathway	6/153	0.18522459356803278	0.7408983742721311	0	0	1.5686274509803921	2.644997915204205	CACNA2D3;ADCY3;CAMK1;PRKACA;PLCB2;MAPK3
Protein digestion and absorption	4/90	0.18828953531711135	0.7435022676624397	0	0	1.7777777777777777	2.968487856688808	KCNQ1;COL6A2;SLC16A10;SLC8A1
Long-term depression	3/60	0.18933665205922548	0.7381732763828032	0	0	2.0	3.3284572412017854	PPP2CB;PLCB2;MAPK3
Cushing syndrome	6/155	0.19279598910173565	0.7422645580416822	0	0	1.5483870967741935	2.548835149062689	KMT2D;FZD7;ADCY3;PRKACA;PLCB2;MAPK3
Hepatitis C	6/155	0.19279598910173565	0.733100798065859	0	0	1.5483870967741935	2.548835149062689	PPP2CB;BAX;BAK1;EIF2S1;YWHAG;MAPK3
Human cytomegalovirus infection	8/225	0.20294459162437736	0.7622796856135149	0	0	1.422222222222222	2.268191694023834	RHEB;GNG4;ADCY3;BAX;BAK1;PRKACA;PLCB2;MAPK3
Wnt signaling pathway	6/158	0.20436847453628693	0.7583793994840526	0	0	1.5189873417721518	2.4118946836174078	DAAM1;FZD7;CACYBP;PRKACA;PLCB2;PPARD
Basal cell carcinoma	3/63	0.20860938631238252	0.7649010831454025	0	0	1.9047619047619047	2.985317601379297	FZD7;BAX;BAK1
NF-kappa B signaling pathway	4/95	0.21407627612000896	0.7757116828819147	0	0	1.6842105263157894	2.5960806686302367	TNFSF14;BTK;PLCG1;LTBR
Alanine, aspartate and glutamate metabolism	2/35	0.21773131350006625	0.7797819134653535	0	0	2.2857142857142856	3.484556533108	ALDH4A1;GOT1
Amoebiasis	4/96	0.21934791524686295	0.7765420447819976	0	0	1.6666666666666665	2.5284935927439762	ARG2;CD1D;PRKACA;PLCB2
Central carbon metabolism in cancer	3/65	0.2216910070831208	0.7759185247909227	0	0	1.8461538461538463	2.7811767260910543	HK3;MET;MAPK3
Cortisol synthesis and secretion	3/65	0.2216910070831208	0.7672003391191147	0	0	1.8461538461538463	2.7811767260910543	ADCY3;PRKACA;PLCB2
DNA replication	2/36	0.22698728149273847	0.7768009188862605	0	0	2.222222222222222	3.2952473149705526	PCNA;RPA3
Tyrosine metabolism	2/36	0.22698728149273847	0.7682646450523456	0	0	2.222222222222222	3.2952473149705526	GOT1;ALDH3B1
Aldosterone synthesis and secretion	4/98	0.2299929805556841	0.7699765001212033	0	0	1.6326530612244896	2.3995207997514747	ADCY3;CAMK1;PRKACA;PLCB2
Dopaminergic synapse	5/131	0.23072798787052096	0.7641314006894672	0	0	1.5267175572519083	2.2389554259440514	PPP2CB;GSK3A;GNG4;PRKACA;PLCB2
Long-term potentiation	3/67	0.23493078009641188	0.7697731943584559	0	0	1.7910447761194028	2.594264527179215	PRKACA;PLCB2;MAPK3
Vascular smooth muscle contraction	5/132	0.23533006344596197	0.7629648372774345	0	0	1.5151515151515151	2.1920700378167894	ADCY3;PRKACA;PLA2G6;PLCB2;MAPK3
Phosphatidylinositol signaling system	4/99	0.23536329754558818	0.7551239129587621	0	0	1.6161616161616161	2.337979816697194	INPPL1;PLCG1;DGKZ;PLCB2
Progesterone-mediated oocyte maturation	4/99	0.23536329754558818	0.7473391303509398	0	0	1.6161616161616161	2.337979816697194	ADCY3;PRKACA;ANAPC2;MAPK3
Primary immunodeficiency	2/37	0.2362702199007159	0.7425635482593929	0	0	2.1621621621621623	3.1195224419228023	CD4;BTK
AGE-RAGE signaling pathway in diabetic complications	4/100	0.24076340791661854	0.7490417135183688	0	0	1.5999999999999999	2.2783048601180695	BAX;PLCG1;PLCB2;MAPK3
HIF-1 signaling pathway	4/100	0.24076340791661854	0.7415512963831852	0	0	1.5999999999999999	2.2783048601180695	HK3;PLCG1;LTBR;MAPK3
Epithelial cell signaling in Helicobacter pylori infection	3/68	0.2416025942539262	0.7367683072297947	0	0	1.7647058823529411	2.5066960150114252	PLCG1;MET;ATP6V1D
Glycolysis / Gluconeogenesis	3/68	0.2416025942539262	0.7295450885314634	0	0	1.7647058823529411	2.5066960150114252	HK3;ALDH3B1;BPGM
Ubiquinone and other terpenoid-quinone biosynthesis	1/11	0.2431315551769016	0.7270341649950067	0	0	3.6363636363636362	5.142373101111616	NQO1
T cell receptor signaling pathway	4/101	0.24619177364498787	0.7291064065640025	0	0	1.584158415841584	2.220426897571902	CD4;PLCG1;MAP2K7;MAPK3
Renin secretion	3/69	0.24830518328238543	0.7283618709616639	0	0	1.7391304347826086	2.4227768897492368	PDE1B;PRKACA;PLCB2
Glucagon signaling pathway	4/103	0.2571271620434609	0.7471242066923204	0	0	1.553398058252427	2.1098012000212023	PYGL;PRKACA;ACACB;PLCB2
Rap1 signaling pathway	7/206	0.25773585549622413	0.7418938644190377	0	0	1.3592233009708736	1.8428621827124072	CSF1R;ADCY3;PLCG1;RASGRP2;PLCB2;MET;MAPK3
Estrogen signaling pathway	5/137	0.2587049099112584	0.7377880764135888	0	0	1.45985401459854	1.97382074569392	ADCY3;HSPA2;PRKACA;PLCB2;MAPK3
B cell receptor signaling pathway	3/71	0.26179144524840503	0.7397409645551262	0	0	1.6901408450704225	2.2651387651401085	INPPL1;BTK;MAPK3
Fluid shear stress and atherosclerosis	5/139	0.26820709009249616	0.7509798522589892	0	0	1.4388489208633093	1.8935192412132424	NQO1;NCF1;CTSL;TXN;MAP2K7
Adherens junction	3/72	0.2685696227705788	0.7452202145345789	0	0	1.6666666666666665	2.1910751599377134	WAS;MET;MAPK3
Bile secretion	3/72	0.2685696227705788	0.7385664626190916	0	0	1.6666666666666665	2.1910751599377134	EPHX1;ADCY3;PRKACA
PI3K-Akt signaling pathway	11/354	0.273425868212789	0.745266968226009	0	0	1.2429378531073447	1.6117482674426946	PPP2CB;CSF1R;RHEB;GNG4;ITGA2;COL6A2;SPP1;PKN1;MET;YWHAG;MAPK3
Fatty acid biosynthesis	1/13	0.28052310882224873	0.7579045396250229	0	0	3.076923076923077	3.911074378522308	ACACB
Human immunodeficiency virus 1 infection	7/212	0.2808834715337439	0.7522792107164619	0	0	1.320754716981132	1.6771146630101066	CD4;GNG4;BAX;PLCG1;BAK1;MAP2K7;MAPK3
PPAR signaling pathway	3/74	0.28218271785894006	0.7492437681082201	0	0	1.6216216216216217	2.051676457611424	FADS2;SLC27A2;PPARD
Insulin resistance	4/108	0.2848542905983054	0.7498728333698981	0	0	1.4814814814814814	1.8604110970526841	PYGL;SLC27A3;SLC27A2;ACACB
Pancreatic cancer	3/75	0.2890124517878938	0.7543714843277228	0	0	1.5999999999999999	1.986056809642578	BAX;BAK1;MAPK3
Chronic myeloid leukemia	3/76	0.2958542767561014	0.7657404810157918	0	0	1.5789473684210524	1.9229814539020869	BAX;BAK1;MAPK3
Axon guidance	6/181	0.2999028666848604	0.7697506911578084	0	0	1.3259668508287292	1.5968574158723403	EFNB2;NTNG2;FES;PLCG1;MET;MAPK3
Carbohydrate digestion and absorption	2/44	0.30144914903771564	0.767325106641458	0	0	1.8181818181818181	2.180279885359369	HK3;PLCB2
Antigen processing and presentation	3/77	0.30270573541973567	0.7642079222072015	0	0	1.5584415584415583	1.8623284918379568	CD4;CTSL;HSPA2
ABC transporters	2/45	0.31071849114810757	0.778059311167619	0	0	1.7777777777777777	2.077987466447498	ABCA2;ABCD1
Glycosphingolipid biosynthesis	2/45	0.31071849114810757	0.7717846393033639	0	0	1.7777777777777777	2.077987466447498	FUT7;GLA
Retrograde endocannabinoid signaling	5/148	0.3117935434195852	0.768259290985858	0	0	1.3513513513513513	1.5748838243444059	GNG4;ADCY3;PRKACA;PLCB2;MAPK3
Serotonergic synapse	4/113	0.31299039884400204	0.7650876416186716	0	0	1.415929203539823	1.6447189572138212	GNG4;PRKACA;PLCB2;MAPK3
Gastric cancer	5/149	0.316701376398177	0.7680631805562089	0	0	1.3422818791946307	1.5433503078978634	FZD7;BAX;BAK1;MET;MAPK3
Type II diabetes mellitus	2/46	0.3199619156443703	0.7699083595192661	0	0	1.7391304347826086	1.981831832838938	HK3;MAPK3
Kaposi sarcoma-associated herpesvirus infection	6/186	0.3217923077934855	0.7683103162821204	0	0	1.2903225806451613	1.463030901156993	GNG4;BAX;PLCG1;BAK1;MAP2K7;MAPK3
Cysteine and methionine metabolism	2/47	0.32917493125894143	0.7798913755981074	0	0	1.7021276595744679	1.891346320966911	GOT1;GCLM
Hedgehog signaling pathway	2/47	0.32917493125894143	0.7739380063187324	0	0	1.7021276595744679	1.891346320966911	ARRB1;PRKACA
Sphingolipid metabolism	2/47	0.32917493125894143	0.7680748396041966	0	0	1.7021276595744679	1.891346320966911	ARSA;GLA
Phagosome	5/152	0.33147910049577933	0.7676358116744364	0	0	1.3157894736842104	1.4528822586911272	NCF1;CTSL;ITGA2;ATP6V1D;FCGR2C
Chemical carcinogenesis	3/82	0.33702536869684624	0.7746553250643929	0	0	1.4634146341463412	1.5916054733134235	SULT1A1;ALDH3B1;EPHX1
ECM-receptor interaction	3/82	0.33702536869684624	0.7689171374713233	0	0	1.4634146341463412	1.5916054733134235	ITGA2;COL6A2;SPP1
Notch signaling pathway	2/48	0.3383532866029959	0.7662706784832554	0	0	1.6666666666666665	1.8061078378867632	KAT2A;RFNG
Peroxisome	3/83	0.34388610305783524	0.7731162024949872	0	0	1.4457831325301203	1.5432936465472034	PRDX1;ABCD1;SLC27A2
Taste transduction	3/83	0.34388610305783524	0.7675139111725597	0	0	1.4457831325301203	1.5432936465472034	PDE1B;PRKACA;PLCB2
Sphingolipid signaling pathway	4/119	0.34704829641584545	0.7689991028494992	0	0	1.3445378151260503	1.4229127071807743	PPP2CB;BAX;PLCB2;MAPK3
Ovarian steroidogenesis	2/49	0.3474929610282407	0.7644845142621295	0	0	1.6326530612244896	1.7257320330061812	ADCY3;PRKACA
Selenocompound metabolism	1/17	0.3498657220916832	0.7642456908102017	0	0	2.352941176470588	2.4710725865370216	TXNRD1
N-Glycan biosynthesis	2/50	0.3565901556321914	0.7734490699627813	0	0	1.5999999999999999	1.6498690882006875	GANAB;MGAT2
ErbB signaling pathway	3/85	0.3575874776802259	0.770188413465102	0	0	1.4117647058823528	1.4518238879557512	PLCG1;MAP2K7;MAPK3
Colorectal cancer	3/86	0.36442414082249097	0.7794627456481057	0	0	1.3953488372093021	1.4085165595114748	BAX;BAK1;MAPK3
Insulin secretion	3/86	0.36442414082249097	0.7740871405057049	0	0	1.3953488372093021	1.4085165595114748	ADCY3;PRKACA;PLCB2
Salmonella infection	3/86	0.36442414082249097	0.7687851737899124	0	0	1.3953488372093021	1.4085165595114748	WAS;PKN1;MAPK3
Hippo signaling pathway	5/160	0.37113057249185394	0.7776069137924558	0	0	1.25	1.239001663595338	PPP2CB;RASSF4;FZD7;TP53BP2;YWHAG
Glycosaminoglycan degradation	1/19	0.3819938041881401	0.7949600789861294	0	0	2.1052631578947367	2.0260018734944683	IDUA
Pantothenate and CoA biosynthesis	1/19	0.3819938041881401	0.7896247764425983	0	0	2.1052631578947367	2.0260018734944683	AASDHPPT
GABAergic synapse	3/89	0.38485531890079877	0.7902362548096401	0	0	1.348314606741573	1.2874891825427501	GNG4;ADCY3;PRKACA
Salivary secretion	3/90	0.39163344766088204	0.7988284892685541	0	0	1.3333333333333333	1.2499052788690577	ADCY3;PRKACA;PLCB2
TGF-beta signaling pathway	3/90	0.39163344766088204	0.793573038681261	0	0	1.3333333333333333	1.2499052788690577	PPP2CB;ID3;MAPK3
Fanconi anemia pathway	2/54	0.3924854550749619	0.7901014389744332	0	0	1.4814814814814814	1.385564147526165	RPA3;TELO2
cGMP-PKG signaling pathway	5/166	0.40090416687703195	0.8018083337540639	0	0	1.2048192771084336	1.1012444163628623	ADCY3;VDAC1;PLCB2;SLC8A1;MAPK3
Legionellosis	2/55	0.40132045183103177	0.7974625752513406	0	0	1.4545454545454544	1.3279927840918175	CR1;HSPA2
Regulation of lipolysis in adipocytes	2/55	0.40132045183103177	0.7923506356663961	0	0	1.4545454545454544	1.3279927840918175	ADCY3;PRKACA
Purine metabolism	4/129	0.40381118360940044	0.7921900926859575	0	0	1.2403100775193798	1.1247229489297248	PNP;PDE1B;ADCY3;AK6
Th1 and Th2 cell differentiation	3/92	0.40513108190704056	0.7897491976415727	0	0	1.3043478260869563	1.1785364415810688	CD4;PLCG1;MAPK3
Glutathione metabolism	2/56	0.41009437639646396	0.7943966536484962	0	0	1.4285714285714284	1.273382799199648	GGT7;GCLM
Small cell lung cancer	3/93	0.41184736294433893	0.7928061736678524	0	0	1.2903225806451613	1.1446483568607568	ITGA2;BAX;BAK1
Influenza A	5/171	0.425602818167362	0.8141966956245187	0	0	1.1695906432748537	0.999121309172849	VDAC1;HSPA2;MAP2K7;EIF2S1;MAPK3
Other types of O-glycan biosynthesis	1/22	0.42723918724304594	0.812281911548507	0	0	1.8181818181818181	1.5462023001914358	RFNG
Lysine degradation	2/59	0.43602582146324703	0.8239015522127612	0	0	1.3559322033898304	1.1254966967419524	KMT2D;PLOD1
VEGF signaling pathway	2/59	0.43602582146324703	0.8188777622602443	0	0	1.3559322033898304	1.1254966967419524	PLCG1;MAPK3
Glycerophospholipid metabolism	3/97	0.4384603644337263	0.8184593469429557	0	0	1.2371134020618557	1.0199825075033913	PNPLA7;PLA2G6;DGKZ
Histidine metabolism	1/23	0.4415739476417069	0.8193058787569019	0	0	1.7391304347826086	1.4215822280628116	ALDH3B1
Pancreatic secretion	3/98	0.4450435426086273	0.8207988690027377	0	0	1.2244897959183672	0.9913263098498469	KCNQ1;ADCY3;PLCB2
Glycerolipid metabolism	2/61	0.4529669891745948	0.8304394801534238	0	0	1.3114754098360655	1.0386046265359035	DGKZ;GLA
Measles	4/138	0.454097806284179	0.8275865345297464	0	0	1.1594202898550725	0.9152958513611567	BAX;HSPA2;BAK1;EIF2S1
Vitamin digestion and absorption	1/24	0.455550643812525	0.8253505782015159	0	0	1.6666666666666665	1.310413975931712	BTD
Tuberculosis	5/179	0.4646752739691283	0.8369589729970264	0	0	1.1173184357541899	0.8563312322847955	CR1;CARD9;BAX;FCGR2C;MAPK3
Alcoholism	5/180	0.4695071787707449	0.840745413147613	0	0	1.111111111111111	0.8400796557824288	HDAC10;GNG4;PKIA;PRKACA;MAPK3
Chagas disease (American trypanosomiasis)	3/103	0.47747528768906305	0.8500716104522048	0	0	1.1650485436893203	0.8612538337064508	PPP2CB;PLCB2;MAPK3
Toll-like receptor signaling pathway	3/104	0.4838567938447761	0.8564821408286841	0	0	1.1538461538461537	0.8376534190762757	SPP1;MAP2K7;MAPK3
Shigellosis	2/65	0.48595425402499	0.8552794870839824	0	0	1.2307692307692308	0.8881732763477085	WAS;MAPK3
Cell adhesion molecules (CAMs)	4/145	0.49222470946858343	0.861393241570021	0	0	1.103448275862069	0.7821461409053762	SPN;NTNG2;CD4;PVR
Aminoacyl-tRNA biosynthesis	2/66	0.49400617659427287	0.8596265671809946	0	0	1.2121212121212122	0.8547966771455834	TARS;YARS2
Biosynthesis of unsaturated fatty acids	1/27	0.49542050679657673	0.857244472434526	0	0	1.4814814814814814	1.0405161012766946	FADS2
Collecting duct acid secretion	1/27	0.49542050679657673	0.8524553971695287	0	0	1.4814814814814814	1.0405161012766946	ATP6V1D
Transcriptional misregulation in cancer	5/186	0.4981933861356625	0.8524642384988002	0	0	1.075268817204301	0.7492117760889532	CSF1R;SPI1;BAX;BAK1;MET
Th17 cell differentiation	3/107	0.5027730441661714	0.8555475005700597	0	0	1.1214953271028036	0.7711585964262758	CD4;PLCG1;MAPK3
Breast cancer	4/147	0.5029167460190818	0.8510898778784461	0	0	1.0884353741496597	0.748114979541874	FZD7;BAX;BAK1;MAPK3
Renal cell carcinoma	2/69	0.5176757123539347	0.8712793410109939	0	0	1.1594202898550725	0.7633695892092621	MET;MAPK3
Thermogenesis	6/231	0.5199017221199351	0.8702702739833696	0	0	1.0389610389610389	0.67960049993958	COA3;SMARCD3;RHEB;ADCY3;PRKACA;COA6
Linoleic acid metabolism	1/29	0.5203679297086519	0.8663422829744042	0	0	1.379310344827586	0.9009919454829998	PLA2G6
Nicotinate and nicotinamide metabolism	1/30	0.5323761135569396	0.8815690482555774	0	0	1.3333333333333333	0.8405400787509358	PNP
Pentose phosphate pathway	1/30	0.5323761135569396	0.8768547752702534	0	0	1.3333333333333333	0.8405400787509358	H6PD
Circadian rhythm	1/31	0.5440842429149877	0.8913720575415756	0	0	1.2903225806451613	0.7853563687947012	NR1D1
RNA polymerase	1/31	0.5440842429149877	0.8866558032688688	0	0	1.2903225806451613	0.7853563687947012	POLR2D
beta-Alanine metabolism	1/31	0.5440842429149877	0.88198919377798	0	0	1.2903225806451613	0.7853563687947012	ALDH3B1
Bacterial invasion of epithelial cells	2/74	0.5554545611303542	0.8957068315609901	0	0	1.0810810810810811	0.635641590695438	WAS;MET
Metabolism of xenobiotics by cytochrome P450	2/74	0.5554545611303542	0.8910416918132765	0	0	1.0810810810810811	0.635641590695438	ALDH3B1;EPHX1
Propanoate metabolism	1/32	0.5554998006860319	0.8864970912502478	0	0	1.25	0.7348587858794243	ACACB
Focal adhesion	5/199	0.5581355275127633	0.8861120746078922	0	0	1.0050251256281406	0.5860838846676963	ITGA2;COL6A2;SPP1;MET;MAPK3
Base excision repair	1/33	0.5666300836000462	0.8949849525580216	0	0	1.2121212121212122	0.6885437552033686	PCNA
Fructose and mannose metabolism	1/33	0.5666300836000462	0.8904187028000725	0	0	1.2121212121212122	0.6885437552033686	HK3
Cellular senescence	4/160	0.5697792723914314	0.8908224157185831	0	0	1.0	0.5625062345694026	RHEB;VDAC1;CAPN1;MAPK3
SNARE interactions in vesicular transport	1/34	0.5774822066735724	0.898305654825557	0	0	1.176470588235294	0.6459737035478923	BET1
Necroptosis	4/162	0.5796164189136505	0.8970947589216298	0	0	0.9876543209876543	0.5386555465960212	BAX;VDAC1;CAPN1;PYGL
AMPK signaling pathway	3/120	0.5803125850880102	0.8936813810355357	0	0	1.0	0.5441883808106572	PPP2CB;RHEB;ACACB
Cardiac muscle contraction	2/78	0.5841351052931448	0.8950925991556646	0	0	1.0256410256410255	0.5514081827999194	CACNA2D3;SLC8A1
Hepatitis B	4/163	0.5844865947758509	0.8911973821334755	0	0	0.9815950920245399	0.5271376027958177	PCNA;BAX;MAP2K7;MAPK3
RNA transport	4/165	0.5941283901229872	0.9014361781176358	0	0	0.9696969696969696	0.5048822671391618	EIF2B2;EIF2S1;RPP38;RAN
Cell cycle	3/124	0.6025842683865784	0.9097840914856183	0	0	0.9677419354838709	0.49018815373105273	PCNA;YWHAG;ANAPC2
African trypanosomiasis	1/37	0.6084381377362886	0.9141412020623263	0	0	1.0810810810810811	0.5371459840670496	PLCB2
Aldosterone-regulated sodium reabsorption	1/37	0.6084381377362886	0.9097036234115383	0	0	1.0810810810810811	0.5371459840670496	MAPK3
Alzheimer disease	4/171	0.6222432337122208	0.9258498356684252	0	0	0.935672514619883	0.44390569515713546	LRP1;CAPN1;PLCB2;MAPK3
Pyruvate metabolism	1/39	0.6278072988155387	0.9296377309383937	0	0	1.0256410256410255	0.4774584703811021	ACACB
Glycine, serine and threonine metabolism	1/40	0.6371302636481142	0.9389288095866947	0	0	1.0	0.4507811487933908	BPGM
Nicotine addiction	1/40	0.6371302636481142	0.9344577200172342	0	0	1.0	0.4507811487933908	CHRNA6
FoxO signaling pathway	3/132	0.6447354146223417	0.9411303682638922	0	0	0.9090909090909091	0.399013869302999	HOMER1;AGAP2;MAPK3
Bladder cancer	1/41	0.6462201541186453	0.9388481484365224	0	0	0.975609756097561	0.42596589015410175	MAPK3
Homologous recombination	1/41	0.6462201541186453	0.9344404106504354	0	0	0.975609756097561	0.42596589015410175	RPA3
Rheumatoid arthritis	2/91	0.6677839316144591	0.9611095838189412	0	0	0.8791208791208791	0.3549807590642075	CTSL;ATP6V1D
mRNA surveillance pathway	2/91	0.6677839316144591	0.9566393066848996	0	0	0.8791208791208791	0.3549807590642075	PPP2CB;PELO
Signaling pathways regulating pluripotency of stem cells	3/139	0.678947280053301	0.9681285289648921	0	0	0.8633093525179856	0.3342835665780219	FZD7;ID3;MAPK3
IL-17 signaling pathway	2/93	0.6793739096257446	0.9642726459204117	0	0	0.8602150537634409	0.33254505468787643	CCL7;MAPK3
Parkinson disease	3/142	0.6928430087684716	0.9788791133059139	0	0	0.8450704225352113	0.3101001498841745	LRRK2;VDAC1;PRKACA
Ether lipid metabolism	1/47	0.69618066242957	0.9791033973895322	0	0	0.8510638297872339	0.30820942968045956	PLA2G6
Amino sugar and nucleotide sugar metabolism	1/48	0.7037940023867141	0.9853116033413997	0	0	0.8333333333333333	0.29272464657414204	HK3
Intestinal immune network for IgA production	1/48	0.7037940023867141	0.9808531797968685	0	0	0.8333333333333333	0.29272464657414204	LTBR
Cocaine addiction	1/49	0.7112169323217401	0.9867334015995313	0	0	0.8163265306122448	0.27818594854238055	PRKACA
Huntington disease	4/193	0.7143361735495651	0.9866167778173366	0	0	0.8290155440414507	0.27888215224615026	POLR2D;BAX;VDAC1;PLCB2
Non-alcoholic fatty liver disease (NAFLD)	3/149	0.7234931524735302	0.994803084651104	0	0	0.8053691275167785	0.26066915226933807	GSK3A;BAX;EIF2S1
Amyotrophic lateral sclerosis (ALS)	1/51	0.7255104548045064	0.9931432003546131	0	0	0.7843137254901961	0.25167042845488546	BAX
Mineral absorption	1/51	0.7255104548045064	0.988748761414991	0	0	0.7843137254901961	0.25167042845488546	SLC8A1
Endocytosis	5/244	0.733203100924348	0.9948306391396441	0	0	0.8196721311475409	0.25437092928144645	AGAP2;WAS;ARRB1;HSPA2;EPN1
C-type lectin receptor signaling pathway	2/104	0.737315155331438	0.9960222273775565	0	0	0.7692307692307693	0.23441527617042462	CARD9;MAPK3
Epstein-Barr virus infection	4/201	0.7434367888046584	0.9999062486979685	0	0	0.7960199004975124	0.2359972418836174	BTK;BAX;BAK1;MAP2K7
Cytokine-cytokine receptor interaction	6/294	0.7471511353125235	1.0	0	0	0.8163265306122448	0.2379492173646253	CSF1R;CD4;TNFSF14;CCL7;TNFSF12;LTBR
Pathogenic Escherichia coli infection	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	WAS
Pyrimidine metabolism	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	PNP
TNF signaling pathway	2/110	0.7649933455424145	1.0	0	0	0.7272727272727272	0.1948277409678554	MAP2K7;MAPK3
Leukocyte transendothelial migration	2/112	0.7736407907197486	1.0	0	0	0.7142857142857142	0.1833197198535737	NCF1;PLCG1
Toxoplasmosis	2/113	0.7778595415712045	1.0	0	0	0.7079646017699115	0.17784729835672625	HSPA2;MAPK3
Regulation of actin cytoskeleton	4/214	0.7858332662053135	1.0	0	0	0.747663551401869	0.18019486995540682	ITGA2;RDX;WAS;MAPK3
Herpes simplex virus 1 infection	10/492	0.7895164157056408	1.0	0	0	0.8130081300813008	0.19214199428336706	EIF2B2;TNFSF14;RHEB;CARD9;ZNF768;ZNF316;BAX;BAK1;ZNF555;EIF2S1
Arachidonic acid metabolism	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	PLA2G6
Retinol metabolism	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	ALDH1A1
Amphetamine addiction	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	PRKACA
Staphylococcus aureus infection	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	FCGR2C
Adipocytokine signaling pathway	1/69	0.8262150460248844	1.0	0	0	0.5797101449275363	0.11066677859030163	ACACB
Prolactin signaling pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	MAPK3
RIG-I-like receptor signaling pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	TBKBP1
p53 signaling pathway	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	BAX
Natural killer cell mediated cytotoxicity	2/131	0.842793086389536	1.0	0	0	0.6106870229007633	0.10444812227821715	PLCG1;MAPK3
Pertussis	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	MAPK3
Synaptic vesicle cycle	1/78	0.8617428383211508	1.0	0	0	0.5128205128205128	0.07630686371389282	ATP6V1D
RNA degradation	1/79	0.8652127562704516	1.0	0	0	0.5063291139240506	0.07330624875311624	EXOSC3
MicroRNAs in cancer	5/299	0.8712357890016845	1.0	0	0	0.668896321070234	0.09220242681327241	STMN1;RDX;PLCG1;BAK1;MET
cAMP signaling pathway	3/212	0.9025598258552375	1.0	0	0	0.5660377358490566	0.05803035958632898	ADCY3;PRKACA;MAPK3
Prostate cancer	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	MAPK3
Drug metabolism	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	ALDH3B1
Oxidative phosphorylation	1/133	0.9659020359820757	1.0	0	0	0.3007518796992481	0.01043394344030168	ATP6V1D
Olfactory transduction	6/444	0.9676635195271555	1.0	0	0	0.5405405405405406	0.017768030231364113	SLC24A4;PDE1B;ADCY3;ARRB1;PRKACA;SLC8A1
Ubiquitin mediated proteolysis	1/137	0.9692072533500224	1.0	0	0	0.291970802919708	0.009131914223382517	ANAPC2
Neuroactive ligand-receptor interaction	4/338	0.971247082034802	1.0	0	0	0.47337278106508873	0.013810358175036714	NMB;P2RX1;CHRNA6;NMUR1
